1. Home
  2. NXRT vs CGEM Comparison

NXRT vs CGEM Comparison

Compare NXRT & CGEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NexPoint Residential Trust Inc.

NXRT

NexPoint Residential Trust Inc.

HOLD

Current Price

$28.25

Market Cap

761.7M

Sector

Real Estate

ML Signal

HOLD

Logo Cullinan Oncology Inc.

CGEM

Cullinan Oncology Inc.

HOLD

Current Price

$15.54

Market Cap

780.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NXRT
CGEM
Founded
2014
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
761.7M
780.4M
IPO Year
2014
2020

Fundamental Metrics

Financial Performance
Metric
NXRT
CGEM
Price
$28.25
$15.54
Analyst Decision
Hold
Strong Buy
Analyst Count
5
10
Target Price
$36.00
$28.80
AVG Volume (30 Days)
167.6K
703.4K
Earning Date
05-27-2026
03-30-2026
Dividend Yield
7.38%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$251,281,000.00
N/A
Revenue This Year
$4.03
N/A
Revenue Next Year
$4.79
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$27.69
$5.68
52 Week High
$43.13
$15.19

Technical Indicators

Market Signals
Indicator
NXRT
CGEM
Relative Strength Index (RSI) 34.90 74.56
Support Level $27.69 $6.75
Resistance Level $32.12 N/A
Average True Range (ATR) 0.85 0.99
MACD -0.20 0.28
Stochastic Oscillator 11.06 77.70

Price Performance

Historical Comparison
NXRT
CGEM

About NXRT NexPoint Residential Trust Inc.

NexPoint Residential Trust Inc is a real estate investment trust company. Its objectives are to maximize the cash flow and value of properties owned, acquire properties with cash flow growth potential, provide quarterly cash distributions, and achieve long-term capital appreciation for stockholders. The company seeks to achieve these objectives through targeted management and a capex value-add program. It focuses on acquiring multifamily properties in markets with attractive job growth and household formation fundamentals predominantly in the Southeastern and Southwestern United States. The company generates revenue from the rental of multifamily properties.

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

Share on Social Networks: